Kefei Chen

3.2k total citations · 1 hit paper
113 papers, 2.1k citations indexed

About

Kefei Chen is a scholar working on Molecular Biology, Genetics and Hepatology. According to data from OpenAlex, Kefei Chen has authored 113 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 28 papers in Genetics and 26 papers in Hepatology. Recurrent topics in Kefei Chen's work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Genetic Mapping and Diversity in Plants and Animals (16 papers) and Liver Disease and Transplantation (13 papers). Kefei Chen is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Genetic Mapping and Diversity in Plants and Animals (16 papers) and Liver Disease and Transplantation (13 papers). Kefei Chen collaborates with scholars based in China, Australia and United States. Kefei Chen's co-authors include Ian T. Paulsen, Q. Ren, Yonggang Wei, Bo Li, Lawrence B. Schook, Yonggang Wei, Zhenggui Du, Tara Baxter, William M. Muir and Martien A. M. Groenen and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kefei Chen

105 papers receiving 2.0k citations

Hit Papers

Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibro... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kefei Chen China 24 694 346 314 299 296 113 2.1k
Gang Xie China 28 1.6k 2.3× 456 1.3× 410 1.3× 240 0.8× 497 1.7× 143 3.5k
Qi Liu China 34 1.7k 2.4× 324 0.9× 153 0.5× 192 0.6× 555 1.9× 172 3.6k
Kyoko Kobayashi Japan 26 756 1.1× 181 0.5× 163 0.5× 96 0.3× 240 0.8× 84 2.3k
Zeng Wang China 24 898 1.3× 287 0.8× 68 0.2× 112 0.4× 439 1.5× 113 2.2k
Wei Yi China 29 2.9k 4.2× 378 1.1× 393 1.3× 324 1.1× 588 2.0× 129 4.6k
Dongsheng Li China 25 831 1.2× 189 0.5× 55 0.2× 432 1.4× 314 1.1× 115 2.3k
Na Wang China 27 1.0k 1.5× 292 0.8× 55 0.2× 314 1.1× 255 0.9× 191 2.7k
Jie Ma China 21 1.5k 2.2× 168 0.5× 60 0.2× 159 0.5× 265 0.9× 79 2.9k
Feng Xue China 25 649 0.9× 126 0.4× 56 0.2× 148 0.5× 249 0.8× 95 1.7k
Lifang Wang China 27 630 0.9× 96 0.3× 93 0.3× 164 0.5× 209 0.7× 168 2.5k

Countries citing papers authored by Kefei Chen

Since Specialization
Citations

This map shows the geographic impact of Kefei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kefei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kefei Chen more than expected).

Fields of papers citing papers by Kefei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kefei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kefei Chen. The network helps show where Kefei Chen may publish in the future.

Co-authorship network of co-authors of Kefei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Kefei Chen. A scholar is included among the top collaborators of Kefei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kefei Chen. Kefei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Fei, Bo Li, Wei Zhang, et al.. (2024). Accumulation of TOX high mobility group box family member 3 promotes the oncogenesis and development of hepatocellular carcinoma through the MAPK signaling pathway. SHILAP Revista de lepidopterología. 5(3). e510–e510. 3 indexed citations
3.
Shi, Yachen, Jingyu Deng, Qianqian Gao, et al.. (2023). Potential Association of Neutrophil Extracellular Traps With Cognitive Impairment in Cerebral Small Vessel Disease. The Journals of Gerontology Series A. 78(11). 1999–2006. 9 indexed citations
4.
Zhao, Yun, Kefei Chen, Shanjida Rahman, et al.. (2023). Phenotypic Plasticity of Yield and Yield-Related Traits Contributing to the Wheat Yield in a Doubled Haploid Population. Plants. 13(1). 17–17.
5.
Huang, Yi, et al.. (2023). Functions and interaction of plant lipid signalling under abiotic stresses. Plant Biology. 25(3). 361–378. 43 indexed citations
6.
Shi, Yachen, Wei Ji, Lei Li, et al.. (2023). Combination of platelet-to-lymphocyte ratio and D-dimer for the identification of cardiogenic cerebral embolism in non-valvular atrial fibrillation. Frontiers in Neurology. 14. 1069261–1069261. 9 indexed citations
7.
Chen, Kefei, et al.. (2023). Lithospheric thinning beneath the Tengchong volcanic field, Southern China: Insight from Cenozoic calc-alkaline basalts. Frontiers in Earth Science. 11. 2 indexed citations
8.
Chen, Kefei, et al.. (2022). Laparoscopic versus open liver resection for resectable HCC with BCLC stage B: a propensity score-matched analysis. Updates in Surgery. 74(4). 1291–1297. 6 indexed citations
9.
Yang, Yubo, et al.. (2022). Laparoscopic liver resection with “ultrasonic scalpel mimic CUSA" technique. Surgical Endoscopy. 36(12). 8927–8934. 7 indexed citations
10.
Hill, Camilla Beate, Tefera Tolera Angessa, Xiaoqi Zhang, et al.. (2021). A global barley panel revealing genomic signatures of breeding in modern Australian cultivars. The Plant Journal. 106(2). 419–434. 23 indexed citations
11.
Newman, Toby E., Matthew Denton‐Giles, Mark C. Derbyshire, et al.. (2021). Identification of Sources of Sclerotinia sclerotiorum Resistance in a Collection of Wild Cicer Germplasm. Plant Disease. 105(9). 2314–2324. 8 indexed citations
12.
Du, Zhenggui, Yonggang Wei, Kefei Chen, & Bo Li. (2014). Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution's experience with 398 consecutive patients. Hepatobiliary & pancreatic diseases international. 13(2). 153–161. 69 indexed citations
13.
Chen, Kefei, Wei Wu, Xiaoming Zhou, et al.. (2013). Intracisternal administration of SB203580, a p38 mitogen-activated protein kinase inhibitor, attenuates cerebral vasospasm via inhibition of tumor-necrosis factor-α. Journal of Clinical Neuroscience. 20(5). 726–730. 18 indexed citations
14.
Jin, Dong‐Kyu, et al.. (2012). Classification and comprehensive treatment of intraoperative encephalocele in brain injury patients. Zhonghua shenjing waike zazhi. 28(2). 123–127. 1 indexed citations
15.
Chen, Kefei, Wen-Qing Huang, Bin Huang, et al.. (2012). BORIS, Brother of the Regulator of Imprinted Sites, Is Aberrantly Expressed in Hepatocellular Carcinoma. Genetic Testing and Molecular Biomarkers. 17(2). 160–165. 21 indexed citations
16.
Shi, Dongliang, et al.. (2012). Intraoperative monitoring of intracranial pressure in treating severe traumatic brain injury patients. Zhonghua shenjing waike zazhi. 28(2). 116–118. 2 indexed citations
17.
Chen, Kefei, et al.. (2010). Epidermal Growth Factor +61 G/A Polymorphism and the Risk of Hepatocellular Carcinoma in a Chinese Population. Genetic Testing and Molecular Biomarkers. 15(4). 251–255. 18 indexed citations
18.
Schook, Lawrence B., Stacey J. Adam, Laurie A. Rund, et al.. (2008). DNA-based Animal Models of Human Disease: from Genotype to Phenotype. PubMed. 132. 15–25. 12 indexed citations
19.
Chen, Kefei. (2007). On the Linear Complexity of Generalized Legendre Sequences. 1 indexed citations
20.
Ren, Jun, et al.. (2004). AFLP markers for genomic DNA fingerprinting in pigs. 1(1). 9–12. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026